We are live on
!
Find out more
NIM
NEOS Investment Management Portfolio holdings
AUM
$27.1B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$558M
(+53%)
Cap. Flow
+$437M
Cap. Flow
% of AUM
27.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
582
New
73
Increased
454
Reduced
38
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$29.1M |
| 2 |
Apple
AAPL
|
+$26.2M |
| 3 |
NVIDIA
NVDA
|
+$19.5M |
| 4 |
Amazon
AMZN
|
+$16.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$12.5M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$848K |
| 3 |
Goldman Sachs
GS
|
+$583K |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$523K |
| 5 |
Travelers Companies
TRV
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Healthcare | 14.59% |
| 3 | Communication Services | 10.45% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Acadia Healthcare
ACHC
$2.6B
| $206K | 0.01% |
+2,596
| New | +$212K |
|
552
Molson Coors Class B
TAP
$7.35B
| $204K | 0.01% |
+3,029
| New | +$192K |
|
553
Jazz Pharmaceuticals
JAZZ
$15.8B
| $201K | 0.01% |
+1,672
| New | +$205K |
|
|
DAY
554
DELISTED
Dayforce
DAY
| $200K | 0.01% |
+3,028
| New | +$207K |
|
555
Relay Therapeutics
RLAY
$4.18B
| $189K | 0.01% |
22,780
+670
| +3% | +$6.54K |
|
556
Invesco
IVZ
$13.6B
| $182K | 0.01% |
+10,945
| New | +$177K |
|
|
CPRX
557
DELISTED
Catalyst Pharmaceutical
CPRX
| $181K | 0.01% |
+11,352
| New | +$171K |
|
|
TALK
558
DELISTED
Talkspace
TALK
| $162K | 0.01% |
+45,452
| New | +$124K |
|
559
Fate Therapeutics
FATE
$285M
| $146K | 0.01% |
+19,823
| New | +$123K |
|
560
Voyager Therapeutics
VYGR
$190M
| $139K | 0.01% |
+14,960
| New | +$126K |
|
|
PARA
561
DELISTED
Paramount Global Class B
PARA
| $135K | 0.01% |
+11,473
| New | +$144K |
|
562
Cogent Biosciences
COGT
$5.71B
| $123K | 0.01% |
18,301
+5,365
| +41% | +$33.2K |
|
|
MRSN
563
DELISTED
Mersana Therapeutics
MRSN
| $87.2K | 0.01% |
+779
| New | +$77.4K |
|
564
Alector
ALEC
$230M
| $86.4K | 0.01% |
+14,344
| New | +$93.8K |
|
565
Pyxis Oncology
PYXS
$282M
| $69.2K | ﹤0.01% |
+16,238
| New | +$68.3K |
|
566
Lucid Motors
LCID
$1.59B
| $55.1K | ﹤0.01% |
+1,935
| New | +$61.7K |
|
567
Dolby
DLB
$5.63B
| – | – |
-2,709
| Closed | -$233K |
|
568
Franco-Nevada
FNV
$51.1B
| – | – |
-1,911
| Closed | -$212K |
|
569
GXO Logistics
GXO
$5.26B
| – | – |
-5,040
| Closed | -$308K |
|
570
InterDigital
IDCC
$8.42B
| – | – |
-2,932
| Closed | -$318K |
|
571
Kimbell Royalty Partners
KRP
$1.49B
| – | – |
-10,500
| Closed | -$158K |
|
572
Royalty Pharma
RPRX
$26.1B
| – | – |
-8,589
| Closed | -$241K |
|
|
SAND
573
DELISTED
Sandstorm Gold
SAND
| – | – |
-51,786
| Closed | -$260K |
|
574
Triple Flag Precious Metals
TFPM
$6.7B
| – | – |
-11,781
| Closed | -$157K |
|
575
Texas Pacific Land
TPL
$24.7B
| – | – |
-1,323
| Closed | -$231K |
|
Similar funds
RG
LP
RCMU
SC
SO
NEOS Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, NEOS Investment Management held 582 positions worth $1.61B, up 53% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
NEOS Investment Management deployed $437M of net new capital in Q1 2024, opening 73 new positions and adding to 454 existing holdings. Its largest new stake was Keros Therapeutics: 14,264 shares worth $944K.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Goldman Sachs, an estimated $583K trimmed.
- NEOS Investment Management's largest Q1 2024 buy was Keros Therapeutics: 14,264 shares worth $944K.
- NEOS Investment Management added most to Microsoft in Q1 2024, an estimated $29.1M increase.
- NEOS Investment Management's biggest Q1 2024 reduction was Goldman Sachs, cutting an estimated $583K.
- NEOS Investment Management fully exited Vanguard Russell 2000 ETF in Q1 2024, selling an estimated $12.5M.
- NEOS Investment Management's ten largest holdings make up 34% of its $1.61B portfolio in Q1 2024.
- NEOS Investment Management opened 73 new positions and closed 16 in Q1 2024.
- NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $1.61B.
Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.